Twinbeech Capital LP Boosts Stake in Teladoc Health, Inc. (NYSE:TDOC)

Twinbeech Capital LP raised its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 63.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 382,735 shares of the health services provider's stock after purchasing an additional 149,118 shares during the period. Twinbeech Capital LP owned about 0.22% of Teladoc Health worth $3,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in TDOC. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $29,000. Lindbrook Capital LLC increased its stake in Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the last quarter. Sterling Capital Management LLC increased its stake in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares during the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Teladoc Health during the 4th quarter worth approximately $60,000. Finally, Generali Investments Management Co LLC acquired a new position in shares of Teladoc Health in the 4th quarter valued at $64,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.58% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on TDOC. The Goldman Sachs Group cut their price target on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. Jefferies Financial Group reduced their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Wells Fargo & Company dropped their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research note on Thursday, May 8th. Finally, Royal Bank of Canada boosted their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Teladoc Health has an average rating of "Hold" and an average target price of $9.71.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded down $0.09 during trading on Friday, reaching $6.82. The company's stock had a trading volume of 4,118,390 shares, compared to its average volume of 6,241,311. The business has a 50 day moving average price of $7.42 and a 200-day moving average price of $9.29. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company has a market capitalization of $1.20 billion, a P/E ratio of -1.18 and a beta of 1.82. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.